Our new Marketplace Crash Course is here to help. Sign-up for free, learn at your own pace.
Medicare raised premiums late last year in preparation to cover the drug Aduhelm. Ultimately, Medicare rejected coverage of the drug, with limited exceptions.
Government insurer won't cover Aduhelm's $28,000-a-year price tag except for clinical trials.